Analysis of the omega-3 fatty acid content of South African fish oil supplements: A follow-up study

Cardiovascular Journal of Africa

Volumn 24, Issue 8, 2013, Pages 297-302

  Opperman, Maretha ^a   Benade, Spinnler ^a  

^a CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Conjugated dienes; Ethyl esters; Omega 3 fatty acids; Peroxides; Supplement labels

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FATTY ACID ANALYSIS; FOLLOW UP; GAS LIQUID CHROMATOGRAPHY; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; LIPID COMPOSITION; MASS FRAGMENTOGRAPHY; PREGNANT WOMAN; SOUTH AFRICA;

CHROMATOGRAPHY, GAS; CONSUMER PRODUCT SAFETY; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; HUMANS; PRODUCT LABELING; QUALITY CONTROL; RISK ASSESSMENT; SOUTH AFRICA;

EID: 84884492997     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2013-074     Document Type: Article

References (30)

1. Calzolari I, Fumagalli S, Marchionni N, Di Bari M, et al. Polyunsaturated fatty acids and cardiovascular disease. Curr Pharm Des 2009; 15(36): 4094-4102.
2. Calder PC. Fatty acids and inflammation: The cutting edge between food and pharma. Eur J Pharmacol 2011; 668: S50-58.
3. Birch EE, Carlson SE, Hoffman DR, Fitzgerald-Gustafson KM, Fu VL, Drover JR, Castañeda YS, et al. The DIAMOND (DHA Intake And Measurement Of Neural Development) study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 2010; 91(4): 848-859.
4. DeFilippis AP and Sperling LS. Understanding omega-3s. Am Heart J 2006; 151: 564-570.
5. Opperman AM, Marais DW, Benadé AJS. Washout kinetics of eicosapentanoic and docosahexanoic acid from human plasma after supplementation with salmon oil. S Afr J Clin Nutr 2010; 29: S8.
6. Harris WS. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 2007; 55(3): 217-223.
7. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. J Am Med Assoc 2012; 308(10): 1024-1033.
8. Kwak SM, Myung SK, Lee YJ, Seo HG; Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebocontrolled trials. Arch Intern Med 2012; 172(9): 686-694.
9. Jump DB, Depner CM, Tripathy S. Omega-3 fatty acid supplementation and cardiovascular disease. J Lipid Res. jlr.R027904. First Published on August 17, 2012.
10. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 2009; 32(7): 365-372.
11. Aranceta J, Pérez-Rodrigo C. Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: a systematic review. Br J Nutr 2012; 107 Suppl 2: S8-22.
12. International Society for the Study of Fatty Acids and Lipids. Recommendations for the intake of polyunsaturated fatty acids in healthy adults. 2004. http://www.issfal.org.uk/ (accessed 12 December 2012).
13. Opperman AM, Marais DW, Benadé AJS. Analysis of omega-3 fatty acid content of South African fish oil supplements. Cardiovasc J Afr 2011; 22: 324-329.
14. Recknagel RO, Glende EA. Spectrophotometric detection of lipid conjugated dienes. Meth Enzymol 1984; 105: 331-337.
15. Khodaparast MHH, Haghdoost A and Movahhed GG. New source of butein in root of Salvia leriifolia (Nowroozak). J Agric Environ Sci 2008; 4(6): 731-736.
16. Benadé AJ, Fincham JE, Smuts CM, Tung MT, Chalton D, Kruger M, et al. Plasma low density lipoprotein composition in relation to atherosclerosis in nutritionally defined Vervet monkeys. Atherosclerosis 1988; 74(1-2): 157-168.
17. Global Organization for EPA and DHA Omega-3. 2012. GOED voluntary monograph (v. 4). http://www.goedomega3.com [15 February 2013].
18. Food and Drug Administration. New Dietary Ingredients in Dietary Supplements - Background for Industry. FDA. [10 March 2013].
19. European Union's Food Supplements Directive. Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements. [10 March 2013].
20. Turner R, McLean CH, Silvers KM. Are the health benefits of fish oils limited by products of oxidation? Nutr Res Rev 2006; 19(1): 53-62.
21. Spiteller G. The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis. Mol Nutr Food Res 2005; 49(11): 999-1013.
22. Penumetcha M, Khan N, Parthasarathy S. Dietary oxidized fatty acids: an atherogenic risk? J Lipid Res 2000; 41(9): 1473-1480.
23. Staprans I, Pan XM, Rapp JH, Feingold KR. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. Mol Nutr Food Res 2005; 49(11): 1075-1082.
24. Yoerger DM, Best CA, McQuillan BM, Supple GE, Guererro JL, Cluette-Brown JE, Hasaba A, Picard MH, Stone JR, Laposata M. Rapid fatty acid ethyl ester synthesis by porcine myocardium upon ethanol infusion into the left anterior descending coronary artery. Am J Pathol 2006; 168: 1435-1442.
25. Alhomsi K, Selig M, Sustic T, Katrangi E, Weissig V, Laposata M. Induction of apoptosis and necrosis in human peripheral blood mononuclear cells by fatty acid ethyl esters. Alcohol Clin Exp Res 2008; 32: 534-543.
26. Bearer CF, Gould S, Emerson R, Kinnunen P, Cook CS. Fetal alcohol syndrome and fatty acid ethyl esters. Pediatr Res 1992; 31: 492-495.
27. Saghir M, Werner J, Laposata M. Rapid in vivo hydrolysis of fatty acid ethyl esters, toxic nonoxidative ethanol metabolites. Am J Physiol 1997; 273: G184-190.
28. Lopez-Huertas E. The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials. Br J Nutr 2012; 107: S185-194.
29. Mori TA, Burke V, Puddey IB, et al. Purified eicsapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000; 71: 1085-1094.
30. Griffin MD, Sanders TA, Davies IG, et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr 2006; 84: 1290-1298.